Clinical trial
Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With…
NCT00298818 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00298818 |
|---|---|
| Title | Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation |
| Official title | Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation / Developmental Disabilities |
| Lead sponsor | Northwell Health, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Epilepsy, Mental Retardation, Developmental Disabilities |
| Enrollment | 25 |
| Start date | Aug 1, 2002 |
| Primary completion | Dec 1, 2005 |
| Completion | Mar 1, 2008 |
| First posted | Mar 3, 2006 |
| Last update posted | May 20, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: